HanchorBio
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- $10M
Investors
- 5
About HanchorBio
Based in Shanghai, China, and established in 2020, HanchorBio is a biopharmaceutical company that focuses on R&D anti-tumor drugs. It has additional offices in Taipei, Shanghai, and San Francisco. HanchorBio provides biological drug FBDBs, based on the molecular design of peptide-Fc, which can activate the immune system against tumors.
Who invested in HanchorBio
5 investors across 2 rounds
See all investors in HanchorBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HanchorBio
Who invested in HanchorBio?
HanchorBio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HanchorBio raised?
HanchorBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did HanchorBio last raise money?
HanchorBio's most recent round on record is a Series A, in Sep 2022.
What does HanchorBio do?
Based in Shanghai, China, and established in 2020, HanchorBio is a biopharmaceutical company that focuses on R&D anti-tumor drugs.
Where is HanchorBio headquartered?
HanchorBio is headquartered in Shanghai, China.
Which VCs invest in companies like HanchorBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at HanchorBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like HanchorBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.